Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Analysis 2015-2019 and Forecast 2020-2025
- 99S3753797
- 91 Pages
- February 2020
- Healthcare
The global B-Cell Maturation Antigen(BCMA) Targeted Therapies market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of B-Cell Maturation Antigen(BCMA) Targeted Therapies by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Bispecific Antibodies
Antibody Drug Conjugates
Chimeric Antigen Receptor T-Cells
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Transposagen Biopharmaceuticals
Sutro Biopharma
Malin Corporation
Eureka Therapeutics
firstVentury Equity
Five Prime Therapeutics
Credit Suisse Securities
Dana-Farber Cancer Institute
Deerfield Partners
Onyx Pharmaceuticals
Juno Therapeutics
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Liver Cancer
Respiratory Cancer
Brain Cancer
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
1 Industry Overview
1.1 B-Cell Maturation Antigen(BCMA) Targeted Therapies Industry
Figure B-Cell Maturation Antigen(BCMA) Targeted Therapies Industry Chain Structure
1.1.1 Overview
1.1.2 Development of B-Cell Maturation Antigen(BCMA) Targeted Therapies
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of B-Cell Maturation Antigen(BCMA) Targeted Therapies
1.2.2 Downstream
Table Application Segment of B-Cell Maturation Antigen(BCMA) Targeted Therapies
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market 2015-2025, by Application, in USD Million
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market by Type
3.1 By Type
3.1.1 Bispecific Antibodies
Table Major Company List of Bispecific Antibodies
3.1.2 Antibody Drug Conjugates
Table Major Company List of Antibody Drug Conjugates
3.1.3 Chimeric Antigen Receptor T-Cells
Table Major Company List of Chimeric Antigen Receptor T-Cells
3.2 Market Size
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market 2015-2019, by Type, in USD Million
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Growth 2015-2019, by Type, in USD Million
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market 2015-2019, by Type, in Volume
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Growth 2015-2019, by Type, in Volume
3.3 Market Forecast
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Forecast 2020-2025, by Type, in USD Million
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Forecast 2020-2025, by Type, in Volume
4 Major Companies List
4.1 Transposagen Biopharmaceuticals (Company Profile, Sales Data etc.)
4.1.1 Transposagen Biopharmaceuticals Profile
Table Transposagen Biopharmaceuticals Overview List
4.1.2 Transposagen Biopharmaceuticals Products & Services
4.1.3 Transposagen Biopharmaceuticals Business Operation Conditions
Table Business Operation of Transposagen Biopharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Sutro Biopharma (Company Profile, Sales Data etc.)
4.2.1 Sutro Biopharma Profile
Table Sutro Biopharma Overview List
4.2.2 Sutro Biopharma Products & Services
4.2.3 Sutro Biopharma Business Operation Conditions
Table Business Operation of Sutro Biopharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Malin Corporation (Company Profile, Sales Data etc.)
4.3.1 Malin Corporation Profile
Table Malin Corporation Overview List
4.3.2 Malin Corporation Products & Services
4.3.3 Malin Corporation Business Operation Conditions
Table Business Operation of Malin Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Eureka Therapeutics (Company Profile, Sales Data etc.)
4.4.1 Eureka Therapeutics Profile
Table Eureka Therapeutics Overview List
4.4.2 Eureka Therapeutics Products & Services
4.4.3 Eureka Therapeutics Business Operation Conditions
Table Business Operation of Eureka Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 firstVentury Equity (Company Profile, Sales Data etc.)
4.5.1 firstVentury Equity Profile
Table firstVentury Equity Overview List
4.5.2 firstVentury Equity Products & Services
4.5.3 firstVentury Equity Business Operation Conditions
Table Business Operation of firstVentury Equity (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Five Prime Therapeutics (Company Profile, Sales Data etc.)
4.6.1 Five Prime Therapeutics Profile
Table Five Prime Therapeutics Overview List
4.6.2 Five Prime Therapeutics Products & Services
4.6.3 Five Prime Therapeutics Business Operation Conditions
Table Business Operation of Five Prime Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Credit Suisse Securities (Company Profile, Sales Data etc.)
4.7.1 Credit Suisse Securities Profile
Table Credit Suisse Securities Overview List
4.7.2 Credit Suisse Securities Products & Services
4.7.3 Credit Suisse Securities Business Operation Conditions
Table Business Operation of Credit Suisse Securities (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Dana-Farber Cancer Institute (Company Profile, Sales Data etc.)
4.8.1 Dana-Farber Cancer Institute Profile
Table Dana-Farber Cancer Institute Overview List
4.8.2 Dana-Farber Cancer Institute Products & Services
4.8.3 Dana-Farber Cancer Institute Business Operation Conditions
Table Business Operation of Dana-Farber Cancer Institute (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Deerfield Partners (Company Profile, Sales Data etc.)
4.9.1 Deerfield Partners Profile
Table Deerfield Partners Overview List
4.9.2 Deerfield Partners Products & Services
4.9.3 Deerfield Partners Business Operation Conditions
Table Business Operation of Deerfield Partners (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Onyx Pharmaceuticals (Company Profile, Sales Data etc.)
4.10.1 Onyx Pharmaceuticals Profile
Table Onyx Pharmaceuticals Overview List
4.10.2 Onyx Pharmaceuticals Products & Services
4.10.3 Onyx Pharmaceuticals Business Operation Conditions
Table Business Operation of Onyx Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Juno Therapeutics (Company Profile, Sales Data etc.)
4.11.1 Juno Therapeutics Profile
Table Juno Therapeutics Overview List
4.11.2 Juno Therapeutics Products & Services
4.11.3 Juno Therapeutics Business Operation Conditions
Table Business Operation of Juno Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Revenue 2015-2019, by Company, in USD Million
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Revenue Share 2015-2019, by Company, in USD Million
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Revenue Share in 2019, by Company, in USD Million
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume 2015-2019, by Company, in Volume
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Share 2015-2019, by Company, in Volume
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Share in 2019, by Company, in Volume
5.2 Regional Market by Company
Figure North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Concentration, in 2019
Figure Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Market Concentration, in 2019
Figure Asia-Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies MMarket Concentration, in 2019
Figure South America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Concentration, in 2019
Figure Middle East & Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Concentration, in 2019
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Liver Cancer
Figure B-Cell Maturation Antigen(BCMA) Targeted Therapies Demand in Liver Cancer, 2015-2019, in USD Million
Figure B-Cell Maturation Antigen(BCMA) Targeted Therapies Demand in Liver Cancer, 2015-2019, in Volume
6.1.2 Demand in Respiratory Cancer
Figure B-Cell Maturation Antigen(BCMA) Targeted Therapies Demand in Respiratory Cancer, 2015-2019, in USD Million
Figure B-Cell Maturation Antigen(BCMA) Targeted Therapies Demand in Respiratory Cancer, 2015-2019, in Volume
6.1.3 Demand in Brain Cancer
Figure B-Cell Maturation Antigen(BCMA) Targeted Therapies Demand in Brain Cancer, 2015-2019, in USD Million
Figure B-Cell Maturation Antigen(BCMA) Targeted Therapies Demand in Brain Cancer, 2015-2019, in Volume
6.1.4 Demand in Others
Figure B-Cell Maturation Antigen(BCMA) Targeted Therapies Demand in Others, 2015-2019, in USD Million
Figure B-Cell Maturation Antigen(BCMA) Targeted Therapies Demand in Others, 2015-2019, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table B-Cell Maturation Antigen(BCMA) Targeted Therapies Demand Forecast 2020-2025, by Application, in USD Million
Figure B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Growth 2020-2025, by Application, in USD Million
Figure B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share in 2025, by Application, in USD Million
Table B-Cell Maturation Antigen(BCMA) Targeted Therapies Demand Forecast 2020-2025, by Application, in Volume
Table B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Growth 2020-2025, by Application, in Volume
Table B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share in 2025, by Application, in Volume
7 Region Operation
7.1 Regional Production
Table B-Cell Maturation Antigen(BCMA) Targeted Therapies Production 2015-2019, by Region, in USD Million
Table B-Cell Maturation Antigen(BCMA) Targeted Therapies Production 2015-2019, by Region, in Volume
7.2 Regional Market
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market 2015-2019, by Region, in USD Million
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share 2015-2019, by Region, in USD Million
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market 2015-2019, by Region, in Volume
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share 2015-2019, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size and Growth 2015-2019, in USD Million
Figure North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size and Growth 2015-2019, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size 2015-2019, by Country, in USD Million
Table North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size 2015-2019, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size and Growth 2015-2019, in USD Million
Figure Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size and Growth 2015-2019, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size 2015-2019, by Country, in USD Million
Table Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size 2015-2019, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size and Growth 2015-2019, in USD Million
Figure Asia-Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size and Growth 2015-2019, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size 2015-2019, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size and Growth 2015-2019, in USD Million
Figure South America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size and Growth 2015-2019, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size 2015-2019, by Country, in USD Million
Table South America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size 2015-2019, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size and Growth 2015-2019, in USD Million
Figure Middle East & Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size and Growth 2015-2019, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size 2015-2019, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Forecast 2020-2025, by Region, in USD Million
Table B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Forecast 2020-2025, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
Table Upstream Segment of B-Cell Maturation Antigen(BCMA) Targeted Therapies
Table Application Segment of B-Cell Maturation Antigen(BCMA) Targeted Therapies
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market 2015-2025, by Application, in USD Million
Table Major Company List of Antibody Drug Conjugates
Table Major Company List of Chimeric Antigen Receptor T-Cells
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market 2015-2019, by Type, in USD Million
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market 2015-2019, by Type, in Volume
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Forecast 2020-2025, by Type, in USD Million
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Forecast 2020-2025, by Type, in Volume
Table Transposagen Biopharmaceuticals Overview List
Table Business Operation of Transposagen Biopharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sutro Biopharma Overview List
Table Business Operation of Sutro Biopharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Malin Corporation Overview List
Table Business Operation of Malin Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eureka Therapeutics Overview List
Table Business Operation of Eureka Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table firstVentury Equity Overview List
Table Business Operation of firstVentury Equity (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Five Prime Therapeutics Overview List
Table Business Operation of Five Prime Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Credit Suisse Securities Overview List
Table Business Operation of Credit Suisse Securities (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Dana-Farber Cancer Institute Overview List
Table Business Operation of Dana-Farber Cancer Institute (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Deerfield Partners Overview List
Table Business Operation of Deerfield Partners (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Onyx Pharmaceuticals Overview List
Table Business Operation of Onyx Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Juno Therapeutics Overview List
Table Business Operation of Juno Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Revenue 2015-2019, by Company, in USD Million
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Revenue Share 2015-2019, by Company, in USD Million
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume 2015-2019, by Company, in Volume
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Share 2015-2019, by Company, in Volume
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table B-Cell Maturation Antigen(BCMA) Targeted Therapies Demand Forecast 2020-2025, by Application, in USD Million
Table B-Cell Maturation Antigen(BCMA) Targeted Therapies Demand Forecast 2020-2025, by Application, in Volume
Table B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Growth 2020-2025, by Application, in Volume
Table B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share in 2025, by Application, in Volume
Table B-Cell Maturation Antigen(BCMA) Targeted Therapies Production 2015-2019, by Region, in USD Million
Table B-Cell Maturation Antigen(BCMA) Targeted Therapies Production 2015-2019, by Region, in Volume
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market 2015-2019, by Region, in USD Million
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share 2015-2019, by Region, in USD Million
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market 2015-2019, by Region, in Volume
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share 2015-2019, by Region, in Volume
Table North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size 2015-2019, by Country, in USD Million
Table North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size 2015-2019, by Country, in Volume
Table Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size 2015-2019, by Country, in USD Million
Table Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size 2015-2019, by Country, in Volume
Table Asia-Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size 2015-2019, by Country, in Volume
Table South America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size 2015-2019, by Country, in USD Million
Table South America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size 2015-2019, by Country, in Volume
Table Middle East & Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size 2015-2019, by Country, in Volume
Table B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Forecast 2020-2025, by Region, in USD Million
Table B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Forecast 2020-2025, by Region, in Volume
Table Price Factors List
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
